SOLV NYSE Week ended 31 Jul 2026

Weekly Investor Report

Solventum Corp. · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 85.44 USD
9.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 14.6% above the Trend Line and sits at 87.8% of its 52-week range. The latest completed week returned 9.5%, after a 9.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 45/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 54 out of 100
Latest Close 85.44 USD 31 Jul 2026
1W Return 9.5% latest completed week
4W Return 9.2% short-term follow-through
12W Return 16.4% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 34.49% based on similar historical setup states.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.5% Latest completed week; four-week move 9.2%. Indicator stack 30/60 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.49% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 45/100 conviction; expected move 7.6%. News sentiment 52/100 46 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 14.6% above the Trend Line and sits at 87.8% of its 52-week range. The latest completed week returned 9.5%, after a 9.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6312-week average 0.33

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 9.2% over four weeks, 16.4% over 12 weeks, and 19.1% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W9.5%
4W9.2%
12W16.4%
26W11.0%
52W19.1%
Active trend streak2 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.62Latest activity-pressure read.
Pressure change-10.6%Four-week change in activity pressure.
Leadership4.67Latest relative-leadership reading.
RS change203.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength79/100Blend of value, momentum, and quality. Underlying universe rank 22; rank 1 is best.
Value74/100Relative valuation strength. Underlying universe rank 27; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth70/100Revenue and earnings growth. Underlying universe rank 31; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework93/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.4x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
6.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
53.7%
Gross profit retained from each unit of revenue.
Operating margin
24.2%
Operating profit retained from revenue.
Free-cash-flow margin
6.1%
Free cash flow generated from revenue.
Return on invested capital
17.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-0.6%
Latest one-year revenue growth.
EPS growth
277.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-56.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

SOLV shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.68, expected move of 7.6%, and Sharemaestro trend signal active.

Conviction45/100
Expected move7.6%
Put/call volume0.68
Pressure30
Speculation45
Volatility60
Trend agreement62
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 46 relevant articles.

11 positive · 31 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move7.6%Nearest-chain priced movement where available.
52-week drawdown-3.6%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+10.1%Week of 8 May.
Worst week-6.5%Week of 6 Mar.
Latest week+9.5%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses10
Sharp losses4
Recent vol5.1%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis43/100

Latest 12-week confirmation: trend 2/12, activity pressure 11/12, relative leadership 1/12.

Activity pressure 0.63; 1 reversal markers Next-Week ExpectancyNegative 34.49%

Next-week expectancy is negative with a 34.49% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors66/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 67; Small Cap Core rank 66 SVQF93/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 73.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options62/100

SOLV shows bullish options pressure with a 45/100 conviction score, put-call volume ratio of 0.68, expected move of 7.6%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 7.6% Sentiment52/100

Weighted news tone is neutral across 46 relevant articles.

Solventum Corp. stock rises Wednesday, outperforms market Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202685.44 USD9.5%74.53 USD70.75 USD0.624.677.5MOn
24 Jul 202678.01 USD-4.1%74.32 USD70.63 USD0.50-3.423.7MOn
17 Jul 202681.31 USD6.0%74.40 USD70.57 USD0.66-0.165.2MOff
10 Jul 202676.70 USD-2.0%74.41 USD70.48 USD0.60-7.414.6MOff
3 Jul 202678.27 USD-1.6%74.62 USD70.43 USD0.70-4.534.9MOff
26 Jun 202679.53 USD5.4%74.86 USD70.37 USD0.84-1.278.7MOff
19 Jun 202675.43 USD-4.4%75.05 USD70.29 USD0.86-8.826.5MOff
12 Jun 202678.87 USD-2.6%75.30 USD70.24 USD0.91-4.187.8MOff
5 Jun 202681.01 USD8.1%75.19 USD70.17 USD0.89-1.3410.7MOff
29 May 202674.95 USD-2.4%74.88 USD70.07 USD0.74-11.2618.3MOff
22 May 202676.83 USD3.5%74.68 USD70.03 USD0.33-8.127.0MOff
15 May 202674.26 USD1.2%74.50 USD69.97 USD-0.10-10.7410.2MOff
8 May 202673.38 USD10.1%74.43 USD69.93 USD-0.46-12.009.6MOff
1 May 202666.63 USD-2.8%74.33 USD69.90 USD-0.80-18.576.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.